Tosu, Japan

Noriyuki Fujimoto

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Fujimoto. Retrieved from https://idiyas.com/inventor/noriyuki-fujimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noriyuki Fujimoto: Innovator in Pharmaceutical Chemistry

Introduction

Noriyuki Fujimoto is a notable inventor based in Tosu, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on chemical compounds.

Latest Patents

Fujimoto holds a patent for a Diphenylthiazole derivative. This invention showcases his expertise in developing new chemical entities that can have potential applications in medicine.

Career Highlights

He is currently employed at Hisamitsu Pharmaceutical Company, Inc., where he continues to engage in research and development. His work at this esteemed company has allowed him to contribute to advancements in pharmaceutical products.

Collaborations

Fujimoto has collaborated with notable colleagues, including Masaru Saita and Hisataka Inoue. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Noriyuki Fujimoto is a dedicated inventor whose work in pharmaceutical chemistry has led to valuable patents and collaborations. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…